Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
747
NCT00654550
A Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surgery for Nearsightedness
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2008
Completion: Dec 31, 2008
NCT00736593
A Study Evaluating Nexagon™ in the Treatment of Skin Wounds.
Start: Sep 30, 2008
Completion: Apr 30, 2009
NCT00820196
A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)
Phase: Phase 2
Start: Mar 31, 2009
Completion: May 31, 2010
NCT00821561
A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects
Completion: Mar 31, 2010
NCT00820703
The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers
Phase: Phase 1/2
Start: Apr 30, 2009
Completion: Dec 31, 2009
NCT01199588
A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers
Start: May 31, 2011
Completion: Mar 31, 2013
NCT01490879
A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)
Start: Jul 31, 2012
Completion: Apr 30, 2014